UPDATE 1-Sanofi bids $9.3 bln for U.S. cancer drug firm Medivation
April 28, 2016 at 02:56 AM EDT
PARIS/LONDON, April 28 (Reuters) - French pharmaceuticals group Sanofi said on Thursday it had made an offer to buy U.S. cancer treatment firm Medivation in a deal worth about $9.3 billion, marking its return to the biotech takeover trail.
